| Oct 31 |
Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity
|
| Oct 30 |
Alnylam Pharmaceuticals Q3 2024 Earnings Preview
|
| Oct 30 |
Cognizant signs deal to enhance Alnylam’s IT infrastructure
|
| Oct 30 |
Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024
|
| Oct 28 |
Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth
|
| Oct 28 |
Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
| Oct 27 |
Alnylam Pharmaceuticals Q3 Earnings Preview: Key RNAi Catalysts To Watch
|
| Oct 24 |
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
|
| Oct 23 |
Alnylam Pharmaceuticals (ALNY) is a Great Momentum Stock: Should You Buy?
|
| Oct 21 |
NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B
|
